Drugs / 20 micrograms dose H5 VLP
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01244867 | Nov 2010 → Jul 2011 | respiratory tract infectious disorder, viral infectious disease | Medicago | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 20 micrograms dose H5 VLP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01244867 ↗ |